SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting…
Browsing: Cidara
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting…
You should read the following discussion and analysis together with our consolidated financial statements and related notes included…
CD421 is Cidara’s lead oncology candidate. Credit: National Cancer Institute on Unsplash. Cidara Therapeutics has announced the expansion…
Cidara Therapeutics, Inc.Agreement builds upon the existing relationship with WuXi XDC for CMC development and GMP manufacturing of…
SAN DIEGO and SHANGHAI, China, Feb. 01, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…